Tesla’s stock falls as Cybercab launch lands with a thud
The company’s Cybercab rollout won’t be as broad as some investors had hoped.
Similar Posts
NatWest’s new business rates rise for second consecutive week
NatWest has increased fixed rates across almost all of its new business mortgage products, with rises ranging from 0.01 percentage points to 0.2 percentage points since last week. The largest single rise was to the 95% loan-to-value (LTV) five-year fixed purchase rate, which increased from 5.29% to 5.49%, a rise of 0.2 percentage points….
Yang Zhilin: China’s AI genius shooting for the moon
“Baby-faced” billionaire Yang Zhilin recently dealt the biggest shock to Western markets since DeepSeek, wiping hundreds of billions of dollars off the valuations of AI and chip stocks. Kimi K3, developed by Yang’s Moonshot AI, is the most advanced “open-weight” large language model to emerge from China yet, topping many benchmarks with its capabilities “at…
ServiceNow CEO defends the company’s relevancy, touting a kill switch for rogue AI agents
ServiceNow CEO Bill McDermott said on Wednesday that the rapid adoption of artificial intelligence is strengthening the company’s competitive position. His comments come just one day after OpenAI disclosed that one of its advanced AI agents escaped a controlled testing environment during a cybersecurity evaluation and compromised the infrastructure of AI startup Hugging Face before…
South Korean stocks weren’t a big deal in your emerging-markets fund. Artificial intelligence changed that.
Is your emerging-markets fund an accidental bet on AI? Returns for these two ETFs show why it might be.
Mortgage Rates Start New Week Flat
Volatility is always a risk surrounding 3 day holiday weekends when it comes to markets and mortgage rates, but this time around, things have been very calm. The average top-tier 30yr fixed rate remained almost perfectly flat versus last Thursday with the MND index technically falling by 0.01%. This week’s calendar of scheduled events is…
NurExone’s Exo-Top Signs Binding MOU With Made Scientific For U.S. GMP Exosome Manufacturing
(RTTNews) – NurExone Biologic Inc. (NRX.V, NRXBF) announced that its U.S. subsidiary, Exo-Top Inc has signed a binding memorandum of understanding with Made Scientific, Inc to establish an exclusive U.S. Good Manufacturing Practice manufacturing and exosome supply partnership supporting NurExone’s clinical and commercial programs. NurExone develops exosome-based regenerative therapies, and Made Scientific is a U.S.-based…
